DD297168A5 - Neurokinin a-antagonisten und verfahren zu deren herstellung - Google Patents

Neurokinin a-antagonisten und verfahren zu deren herstellung Download PDF

Info

Publication number
DD297168A5
DD297168A5 DD90343398A DD34339890A DD297168A5 DD 297168 A5 DD297168 A5 DD 297168A5 DD 90343398 A DD90343398 A DD 90343398A DD 34339890 A DD34339890 A DD 34339890A DD 297168 A5 DD297168 A5 DD 297168A5
Authority
DD
German Democratic Republic
Prior art keywords
phe
trp
group
derivative according
peptide derivative
Prior art date
Application number
DD90343398A
Other languages
German (de)
English (en)
Inventor
Scott L Harbeson
Stephen H Buck
Original Assignee
������@������@��������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������@��������@���Kk�� filed Critical ������@������@��������@���Kk��
Publication of DD297168A5 publication Critical patent/DD297168A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD90343398A 1989-08-10 1990-08-10 Neurokinin a-antagonisten und verfahren zu deren herstellung DD297168A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39223689A 1989-08-10 1989-08-10

Publications (1)

Publication Number Publication Date
DD297168A5 true DD297168A5 (de) 1992-01-02

Family

ID=23549831

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343398A DD297168A5 (de) 1989-08-10 1990-08-10 Neurokinin a-antagonisten und verfahren zu deren herstellung

Country Status (22)

Country Link
US (1) US5731286A (no)
EP (1) EP0412542B1 (no)
JP (1) JP2829779B2 (no)
KR (1) KR0169123B1 (no)
CN (1) CN1035056C (no)
AR (1) AR246087A1 (no)
AT (1) ATE132503T1 (no)
AU (1) AU638264B2 (no)
CA (1) CA2022740C (no)
DD (1) DD297168A5 (no)
DE (1) DE69024555T2 (no)
DK (1) DK0412542T3 (no)
ES (1) ES2084627T3 (no)
FI (1) FI95913C (no)
GR (1) GR3018984T3 (no)
HU (1) HU206729B (no)
IE (1) IE69382B1 (no)
IL (1) IL95309A (no)
NO (1) NO177715C (no)
NZ (1) NZ234814A (no)
PT (1) PT94952B (no)
ZA (1) ZA906188B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA894533B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Neurokinin a antogonists
DE4034829A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
JPH06509571A (ja) * 1991-08-08 1994-10-27 エイ・メナリニ・インダストリー・ファーマシューティケ・リウニテ・エスアールエル タキキニン拮抗薬としての環状ヘキサペプチドの製法およびその薬学的化合物
US5731285A (en) * 1992-04-15 1998-03-24 A. Menatini Industrie Farmaceutiche Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
JP5866277B2 (ja) * 2009-03-16 2016-02-17 ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント 環状アミノ酸分子およびその製造方法
WO2017079821A1 (en) 2015-11-11 2017-05-18 Encycle Therapeutics, Inc. Fragment synthesis of cyclic peptides
EP3939989A1 (en) 2016-11-11 2022-01-19 Zealand Pharma A/S Cyclic peptides multimers targeting alpha 4beta 7 integrin
EP3621980A4 (en) 2017-05-10 2021-06-30 Zealand Pharma A/S HOMODETIC CYCLIC PEPTIDES TARGETING INTEGRIN ALPHA4 BETA7

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742156A (en) * 1985-09-30 1988-05-03 Mcneilab, Inc. Peptide antagonists of neurokinin B and opthalmic solutions containing them
US4665157A (en) * 1985-09-30 1987-05-12 Mcneilab, Inc. Peptide antagonists of neurokinin B
DE3711335A1 (de) * 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
ZA894533B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Neurokinin a antogonists
FI97540C (fi) * 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
EP0412542A2 (en) 1991-02-13
NO903513D0 (no) 1990-08-09
IE69382B1 (en) 1996-09-04
IL95309A (en) 1995-07-31
US5731286A (en) 1998-03-24
NO903513L (no) 1991-02-11
NO177715B (no) 1995-07-31
CA2022740C (en) 2000-05-02
IE902886A1 (en) 1991-02-27
HUT54713A (en) 1991-03-28
KR910004665A (ko) 1991-03-29
DK0412542T3 (da) 1996-01-29
ES2084627T3 (es) 1996-05-16
FI95913B (fi) 1995-12-29
NZ234814A (en) 1992-03-26
DE69024555D1 (de) 1996-02-15
NO177715C (no) 1995-11-08
JP2829779B2 (ja) 1998-12-02
AR246087A1 (es) 1994-03-30
HU904952D0 (en) 1991-01-28
EP0412542B1 (en) 1996-01-03
CN1035056C (zh) 1997-06-04
CN1049353A (zh) 1991-02-20
HU206729B (en) 1992-12-28
KR0169123B1 (ko) 1999-01-15
FI95913C (fi) 1996-04-10
JPH03141295A (ja) 1991-06-17
AU638264B2 (en) 1993-06-24
FI903922A0 (fi) 1990-08-08
CA2022740A1 (en) 1991-02-11
ATE132503T1 (de) 1996-01-15
DE69024555T2 (de) 1996-05-15
IL95309A0 (en) 1991-06-30
EP0412542A3 (en) 1991-07-24
AU6022290A (en) 1991-05-16
PT94952B (pt) 1997-07-31
PT94952A (pt) 1991-04-18
ZA906188B (en) 1991-06-26
GR3018984T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
DE3786250T2 (de) Phosphinsäure-Derivate.
DE3854159T2 (de) Effektive antagonisten für den das luteinisierende hormon freisetzenden faktor mit unbedeutender histaminfreisetzung.
DE69722651T2 (de) Heptapeptid oxytocin analogen
EP0034259B1 (de) Peptidester, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel beziehungsweise Diagnostica
DE3888921T2 (de) Polypeptide.
DE3689508T2 (de) Peptide.
DD243932A5 (de) Verfahren zur herstellung von n,n'-dialkylguanidino-dipeptiden
DD216717A5 (de) Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten
DD236522A5 (de) Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen
DE3889726T2 (de) Synthetische inhibitoren von säugetier-collagenase.
DD297168A5 (de) Neurokinin a-antagonisten und verfahren zu deren herstellung
WO1996017860A1 (de) Neue dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten
EP0856007B1 (de) Cyclopeptidderivate
DE68916113T2 (de) Neurokinin-A-Antagonisten.
DD200798A5 (de) Verfahren zur herstellung von peptiden
DD200799A5 (de) Verfahren zur herstellung von peptiden
DE69024626T2 (de) Peptidderivate, wertvoll als Antagonisten von Bombesin und Gastrin-freisetzendem Peptid
DE60007345T2 (de) Basische monocyclische verbindungen mit nk-2 antagonistischer wirkung, verfahren zu ihrer herstellung, und sie enthaltende mittel
DE69126254T2 (de) Peptide mit Bombesin/GRP-antagonistischer Wirkung
EP0179352B1 (de) Peptide
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
EP0401507A1 (de) Cyclische Tachykinin-Agonisten
EP0948525B1 (de) Cyclopeptidderivate
EP0876337B1 (de) Neue lh-rh-antagonisten mit verbesserter wirkung
DE60312178T2 (de) Fluoralkylcyclopeptidderivate mit antiintegrinwirkung

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100811